The increasing incidence of thyroid cancer is associated with a higher number of advanced disease characterized by the loss of cancer differentiation and metastatic spread. The knowledge of the molecular pathways involved in the pathogenesis of thyroid cancer has made possible the development of new therapeutic drugs able to blockade the oncogenic kinases (RET/PTC) or signaling kinases (vascular endothelial growth factor receptor [VEGFR]) involved in cellular growth and proliferation. Some clinical trials have been conducted showing the ability of targeted therapies able to inhibit RET(sorafenib, imatinib, vandetanib) in stabilizing the course of the disease. The aim of the introduction of these targeted therapies is to extend life duration assuring a good quality of life; however, further studies are needed to reach these goals.

RET TKI: potential role in thyroid cancers / Antonelli, A; Fallahi, P; Ferrari, Silvia Martina; Mancusi, C; Colaci, Michele; Santarpia, L; Ferri, Clodoveo. - In: CURRENT ONCOLOGY REPORTS. - ISSN 1523-3790. - STAMPA. - 14:2(2012), pp. 97-104. [10.1007/s11912-012-0217-0]

RET TKI: potential role in thyroid cancers.

FERRARI, Silvia Martina;COLACI, Michele;FERRI, Clodoveo
2012

Abstract

The increasing incidence of thyroid cancer is associated with a higher number of advanced disease characterized by the loss of cancer differentiation and metastatic spread. The knowledge of the molecular pathways involved in the pathogenesis of thyroid cancer has made possible the development of new therapeutic drugs able to blockade the oncogenic kinases (RET/PTC) or signaling kinases (vascular endothelial growth factor receptor [VEGFR]) involved in cellular growth and proliferation. Some clinical trials have been conducted showing the ability of targeted therapies able to inhibit RET(sorafenib, imatinib, vandetanib) in stabilizing the course of the disease. The aim of the introduction of these targeted therapies is to extend life duration assuring a good quality of life; however, further studies are needed to reach these goals.
2012
14
2
97
104
RET TKI: potential role in thyroid cancers / Antonelli, A; Fallahi, P; Ferrari, Silvia Martina; Mancusi, C; Colaci, Michele; Santarpia, L; Ferri, Clodoveo. - In: CURRENT ONCOLOGY REPORTS. - ISSN 1523-3790. - STAMPA. - 14:2(2012), pp. 97-104. [10.1007/s11912-012-0217-0]
Antonelli, A; Fallahi, P; Ferrari, Silvia Martina; Mancusi, C; Colaci, Michele; Santarpia, L; Ferri, Clodoveo
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/741479
Citazioni
  • ???jsp.display-item.citation.pmc??? 12
  • Scopus 62
  • ???jsp.display-item.citation.isi??? 55
social impact